Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Hypersensitivity phenotypes associated with genetic and synthetic inhibitor-induced base excision repair deficiency Horton JK; Wilson SHDNA Repair (Amst) 2007[Apr]; 6 (4): 530-43Single-base lesions in DNA are repaired predominantly by base excision repair (BER). DNA polymerase beta (pol beta) is the polymerase of choice in the preferred single-nucleotide BER pathway. The characteristic phenotype of mouse fibroblasts with a deletion of the pol beta gene is moderate hypersensitivity to monofunctional alkylating agents, e.g., methyl methanesulfonate (MMS). Increased sensitivity to MMS is also seen in the absence of pol beta partner proteins XRCC1 and PARP-1, and under conditions where BER efficiency is reduced by synthetic inhibitors. PARP activity plays a major role in protection against MMS-induced cytotoxicity, and cells treated with a combination of non-toxic concentrations of MMS and a PARP inhibitor undergo cell cycle arrest and die by a Chk1-dependent apoptotic pathway. Since BER-deficient cells and tumors are similarly hypersensitive to the clinically used chemotherapeutic methylating agent temozolomide, modulation of DNA damage-induced cell signaling pathways, as well as BER, are attractive targets for potentiating chemotherapy.|*DNA Damage[MESH]|Animals[MESH]|Antineoplastic Agents, Alkylating/toxicity[MESH]|DNA Polymerase beta/antagonists & inhibitors/genetics/*physiology[MESH]|DNA Repair Enzymes/chemistry/genetics/*physiology[MESH]|DNA Repair-Deficiency Disorders/chemically induced/enzymology/*genetics[MESH]|Drug Resistance, Neoplasm/*genetics[MESH]|Humans[MESH]|Methyl Methanesulfonate/toxicity[MESH]|Mice[MESH]|Phenotype[MESH]|Poly(ADP-ribose) Polymerases/genetics/physiology[MESH] |
